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Abstract
Urea (CH6ON2) is one of the main human nitrogen-based metabolic wastes. The concentration of urea in blood lies
between 2.5–7 mM for healthy individuals, and is commonly used as an indicator for several diseases that may alter
this value. Spectrophotometric methods are employed for the determination of blood urea concentration during
clinical assays. Although these methods are sensitive, they make use of toxic reagents and complex reaction
schemes. Therefore, in this research we present the bioelectrochemical determination of urea by the use of the protein urease (E.C.3.1.1.5) along with a nano-platinized boron-doped diamond electrode. This approach has been
proven to be efficient and sensitive providing a platform with detection limits of 1.79 mM (S/N = 3). The linear
range resulted from 1 mM to 25 mM for the determination of urea, and response time of five minutes.
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NH3 þ 2K2 ½HgI4  þ 3OH ! OHg2 ðNH2 ÞI þ 7Iþ 2H2 O
ð1Þ

1 Introduction
The human body produces a variety of biological wastes
as a result of its numerous metabolic pathways. Protein
metabolism is among the most common processes performed by the human body and in general, the majority
of proteins are metabolized in the liver, where urea
(CH6ON2) is produced as one of the main nitrogen-based
wastes. The normal levels of urea in blood lie between
2.5–7 mM [1,2] for healthy individuals, and is commonly
used as an indicator for several diseases. Low urea levels
are mainly related to liver diseases or malfunctioning
whereas high levels of urea are mainly associated to renal
and coronary diseases [3]. Therefore, the monitoring of
urea levels is directly related to kidney function. When
chronic kidney malfunctioning occurs in patients, dialysis
treatment is necessary and urea concentration should
remain approximately in a range of 3–16 mM after such
treatment [1,4].
Indeed, spectrophotometric techniques are mostly employed for the determination of urea levels. These techniques involve the degradation of urea via the enzyme
urease (E.C. 3.5.1.5) to produce ammonia via hydrolysis
[5]. The released ammonia from the enzymatic reaction
should undergo several reaction steps in order to produce
spectrophotometrically active species. The Nessler reaction (Equation 1) [6,7] and the Berthelot reaction (Equation 2) [8] are among the most accepted methods for sensitive and accurate urea determination.
2102

NH3 þ OCl þ 2OH þ 2Phenolate !
Indophenolate þ 3H2 O þ HCl ðwith ½FeðCNÞ5 ONO4 Þ
ð2Þ
However these methods are far from providing fast and
point-of-care testing since the methods are complicated
and require highly trained professionals. Also, some of
the compounds used in these reactions are quite toxic.
Therefore, strategies to provide sensitive and fast measuring while accomplishing point-of-care testing are being
proposed from which amperometric biosensors shed
a bright future. The most common urea amperometric
biosensor is based on the interface of the enzyme urease
and a selective electrode. The electrode can be selective
to ammonium ion (NH4 + ) [1], ammonia [9,10], or to hydronium ion (H3O + ) [11–13] depending on the working
pH of the system since the amount of ammonia produced
and its equilibrium with its conjugate acid will cause
changes in the pH. These systems are designed by entrapping the enzyme in a polymer (e.g. polyvinyl alcohol or
polyacrilamide) while casting the selective sensor or by
microencapsulation of the enzyme [1,10–14]. Therefore,
urea has to diffuse through the polymer to reach the
enzyme, in order for hydrolysis to occur, and then the
product must diffuse to travel through the polymer until
the selective membrane to permeate through it. After

 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim

Electroanalysis 2012, 24, No. 11, 2102 – 2108

This article is a U.S. government work, and is not subject to copyright in the United States.

Urea Bioprobe Based on Platinized Boron-Doped Diamond Electrodes

that, the analyte is detected and an analytical amperometric signal is measured. Generally, these systems have adequate working ranges to measure urea levels, ranging
from 0.03–1 mM to 30–1000 mM [2,10,11,13]. However,
a major disadvantage of these biosensors consists in that
the detection is completely dependent on the diffusion of
the species through the polymer. Also, another disadvantage is that the selective membranes are not fully selective,
allowing similar species to the analyte permeate through
them causing discrepancies in the measurements, which
could provide a false positive result.
For these reasons, in this work we propose a urea bioelectrochemical probe consisting on a boron-doped diamond electrode with platinum nanoparticles deposited at
its surface and the enzyme urease free in buffer solution.
In this system, urea is hydrolyzed by urease in solution,
where the diffusion barrier of urea to urease is expected
to be considerably lower than through a polymer, what
should improve the sensitivity. Then the ammonia is oxidized at the platinized boron-doped diamond electrode
(Pt-BDD), creating an electrochemical signal, as follows:
2NH3 þ OH ! N2 þ 6H2 O þ 6e

ð3Þ

Therefore, the proposed bioelectrochemical probe
should help to improve sensitivity and selectivity, in the
measurements of urea levels, due to the high urease
enzyme selectivity towards urea and the high sensitivity
of the platinum nanoparticles to electroactive compounds,
such as ammonia. Other advantage of this construction is
that the boron-doped diamond electrodes have been
proven to be highly conductive and resistant to nonspecific adsorption. These characteristics are known to minimize any background effects [15].

2 Experimental
2.1 Materials and Apparatus
Urea (ACS reagent, 99.0–100.5 %), urease (E.C.3.5.1.5,
from Canavalia ensiformis (Jack bean) Type VII; initial
activity of 400 000–800 000 units/g solid), potassium phosphate monobasic (KH2PO4), potassium phosphate dibasic
(K2HPO4), sulfuric acid (H2SO4, TraceSELECT Ultra,
 95 % (T)), nitric acid (HNO3), hydrochloric acid (HCl),
potassium chloride (KCl), potassium hydroxide (KOH),
potassium ferricyanide (K3Fe(CN)6), potassium ferrocyanide (K4Fe(CN)6), ammonium sulfate ((NH4)2SO4),
phenol-nitroprusside, alkaline hypochlorite, creatinine
(anhydrous) and potassium hexachloroplatinate IV
(K2PtCl6, 99.99 + % trace metals basis) were all purchased
from Sigma Aldrich (USA) and used without further purification. An HCP-803 potentiostat/galvanostat in low
current mode from BioLogic USA, along with a common
glass three-electrode cell system was used for all the electrochemical procedures. The boron-doped diamond
(BDD) substrate (Element 6, 0.038–0.105 W, [B]:
1020 cm3) was used as the working electrode, Ag/AgCl
Electroanalysis 2012, 24, No. 11, 2102 – 2108

(0.197 vs. NHE) as the reference electrode and a platinum
wire as the counter electrode. A UV-Vis spectrophotometer from Shimadzu Co. was also used along with a 1 cm
path length quartz cuvette.
2.2 Electrode Preparation and Characterization
First, the boron-doped diamond electrodes were oxidized
by sweeping the cell potential between 1.0 V and 2.5 V
vs. Ag/AgCl in a 0.5 M HNO3 solution for 45 consecutive
cycles at a scan rate of 100 mV s1. Thereafter, the electrode was washed several times with deionized water
(Barnstead 18.2 MW) and dried under N2 for further use.
Then, the reversibility capacity of the BDD electrode was
measured using the cyclic voltammetry (CV) technique.
The potential was swept between 0.1 V and 0.6 V vs.
Ag/AgCl in a 1 mM K3Fe(CN)6/1 mM K4Fe(CN)6/0.1 M
KCl for a period of three cycles. This process was performed before and after the electrochemical oxidation.
After the oxidation process, platinum was electrodeposited over the boron-doped diamond electrodes. Scans from
0.2 V and 1.0 V vs. Ag/AgCl in a 1 mM K2PtCl6/0.5 M
H2SO4 solution at scan rate of 300 mV s1was performed
to achieve electrodeposition. Then, the platinized borondoped diamond (Pt-BDD) electrode was thoroughly
washed with deionized water. Immediately after washing,
a cyclic voltammetry was recorded by using a 0.5 M sulfuric acid solution to account for the cleanliness and electrochemical active area of the platinum deposits. Scanning electron microscopy (SEM) images were obtained
using a JEOL 5800LV Scanning Microscope with an electron beam of 20 kV.
2.3 Ammonia Oxidation at Pt-BDD Electrodes (pH 8.3
and 7.4)
The electrochemical oxidation of ammonia at pH 7.4 and
8.3 was investigated with a 0.1 M (NH4)2SO4. In brief, the
linear polarization technique was employed from 0.3 V
to 0.7 V vs. Ag/AgCl at 100 mV/s.
2.4 Urea Bioprobe Measurements
In order to measure the analytical amount of ammonia
molecules being produced via the hydrolysis of urea from
the enzyme urease (E.C.3.5.1.5) a calibration curve was
performed (data not shown). The Weatherburn method
was used following a similar procedure as published elsewhere [16, 17]. In this assay, 50 mL of ammonia solution
of different concentrations were mixed with 500 mL of
phenol-nitroprusside and then with 500 mL of alkaline hypochlorite after vigorous shaking before each addition.
These samples were incubated at 37 8C for 30 minutes
and then measured at a wavelength of 630 nm in a UVVis Spectrophotometer. After having the calibration
curve for ammonia we proceed with the enzymatic assay.
For the enzymatic assay a protein final concentration of
0.02 mg/mL was selected as a first approach. For all ex-
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periments a 100 mM phosphate buffer solution of pH 7.0
and 8.0 was used. To execute the urease assay 100 mL of
a 0.2 mg/mL urease solution was mixed with final urea
concentrations of 10, 50, and 100 mM with the vial completed to 1 mL with PBS. Aliquots of 50 mL of this mixture were extracted over time and mixed with the phenolnitroprusside and sodium alkaline hypochlorite.
Therafter, to test the complete system, a 4 mg/mL
stock solution of urease in 100 mM PBS was prepared
fresh the day of the experiment. Then, 1.25 mL of the
enzyme stock solution and different amounts of urea solutions in stock were poured into the electrochemical cell,
completing with 100 mM PBS to a final volume of 5 mL
in the cell. Therefore, the final concentration of urease in
the cell was around 1 mg/mL, while the urea concentration ranged from 1 mM up to 100 mM. In order to measure only the faradic current (related to the transfer of
electrons during an electrochemical chemical reaction)
the differential pulse voltammetry (DPV) technique was
employed. After letting the enzymatic reaction undergo
for 5 minutes, a DPV was carried out from 0.1 V to
0.7 V vs. Ag/AgCl with a pulse height of 50 mV, pulse duration of 50 ms, step high of 2 mV and step duration of
400 ms.
Finally, in order to determine the specificity of the
system, creatinine was added as interference due to its
similarity. The experiments consisted in two parts, first
the creatinine was measured in the system without urea,
and then both urea and creatinine were measured together in order to observe the effect of its presence. A stock
solution of 100 mM creatinine in 100 mM PBS was prepared to measure 50 mM creatinine in the presence of
0.5 mg/mL urease, 10 mM urea and completing with
100 mM PBS to a final volume of 5 mL in the cell. After
letting the enzymatic reaction undergo for 5 minutes,
a linear polarization was carried out from 0.3 V to 0.7 V
vs. Ag/AgCl.

Fig. 1. Cyclic voltammograms of 1 mM Fe(CN)63/4 in 0.10 M
KCl at a boron doped diamond (BDD) electrode before and
after the oxidation process at a scan rate of 100 mV/s. Inset:
Scanning electron microscope image for the oxidized BDD electrode, at 20 kV and 30  magnification.

tion 2.2. Figure 2 shows an SEM image of the platinized
boron-doped diamond electrode (Pt-BDD), where the
platinum nanoparticles are visible and it is also noticeable
that the platinum nanoparticles showed preference for
being electrodeposited on certain facets of the diamond.
This preferential electrodeposition behavior has been the
subject of investigation in recent years and it is mostly ascribed to the conductivity of the different facets of the
BDD [18].
After each electrodeposition the Pt-BDD was accounted for the electrochemical active surface by calculating

3 Results and Discussion
3.1 Electrode Characterization
Prior to electrochemical deposition, the boron-doped diamond electrodes employed in this research were anodically oxidized in order to create a hydrophobic layer, which
provides a more suitable environment for metal deposition. As shown in Figure 1, after anodic oxidation of
BDD the electrode showed an increment in current of
25 % and better reversibility (0.51 V (non-oxidized) vs.
0.39 V (oxidized)) when tested with a redox couple of
Fe(CN)63/4 in 0.1 M KCl. Also, in this figure an SEM
image is shown as an inset where it can be observed the
difference in coloration of the oxidized part of the electrode (light circle). This data suggests that the electrode
is highly conductive after oxidation and therefore is prepared for further platinum electrodeposition.
Afterwards, platinum was electrodeposited over the
BDD previously oxidized by following procedures in Sec2104
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Fig. 2. Scanning electron microscopy image for the electrodeposited Pt nanoparticles at a boron doped diamond electrode, at
20 kV and 20 k  magnification.
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the area under the hydrogen desorption peaks after running a 0.5 M H2SO4 cyclic voltammetry. Therefore, the results for the proposed sensor are normalized by the effective active area of platinum in the electrode, and shown
as the current density, j. In general after each platinum
electrochemical deposition an approximate area of
0.615 cm2 is attained.

3.2 Ammonia Electrooxidation at Pt-BDD
As explained in Section 1, the proposed sensor employs
the enzyme urease to convert urea to ammonia, and the
ammonia molecules are then electrooxidized at the interface of the Pt-BDD. Therefore, in an effort to understand
the ammonia electrooxidation profile at different pHs at
the Pt-BDD two 0.1 M ammonium sulfate solutions at
pH 7.4 and 8.3 were tested. The pH 7.4 was utilized because at this pH the enzyme has the highest activity according to the vendor, while pH 8.3 was chosen because
at this pH the enzyme is expected to still have considerable activity and the ammonia/ammonium ion equilibrium
is more favorable for the ammonia oxidation since the
chemical equilibrium is shifted to the formation of ammonia. Figure 3 shows the linear polarization of the two
0.1 M (NH4)2SO4 solutions at pH 7.3 and 8.3.
As can be observed the peak current density was
higher for the solution with the higher pH level due to
the expected higher concentration of ammonia due to
shifting in chemical equilibrium. In addition, in this graph
is noticeable that the oxidation potential for ammonia
has shifted to lower values as the pH increase, though
this is predicted by the Nernst equation. Thus, due to the
fact that a higher signal-to-noise ratio can be obtained at
pH 8.3 the sensor experiments were executed at such pH.
As stated above, this pH value satisfies the necessity of

Fig. 3. Linear polarization of the ammonia oxidation at Pt
nanoparticles at a boron doped diamond electrode in an ammonium sulfate solution in phosphate buffer solution at pH 7.4 and
8.3. Scan rate of 100 mV/s.
Electroanalysis 2012, 24, No. 11, 2102 – 2108

a sensitive sensor without losing all enzyme activity,
which is critical for a successful biosensing system.
3.3 Urea Bioprobe Experiments
The biomolecule activity and its ability to recognize an
analyte is perhaps one of the most critical features of a biosensig device. Thus, the activity of the enzyme urease
was determined via the Weatherburn Method. During the
assay, the enzymes activity was measured for two different urea concentrations, 5 mM and 100 mM, and different
pH 7.4 and 8.3. As expected, it was found that the enzymes activity with a urea concentration of 100 mM
(13.0  0.3 mmol ammonia/min mg protein at pH 8.3) was
twice of the activity of that at 5 mM (6.5  0.2 mmol ammonia/min mg protein at same pH), at any given pH.
Also, the higher activity was found for the assay performed at pH 7.4 in comparison to pH 8.3 at both concentrations. Once the biochemical and electrochemical parameters were optimized, the proposed device was tested
as a single unit. Here, the urea degradation by urease and
the in-situ electrooxidation ammonia was carried out and
assessed. For these experiments, all solutions were prepared in phosphate buffer at pH 8.3 and the final concentration of the enzyme in the electrochemical cell was approximately 1 mg/mL after correction by UV-Vis at
280 nm.
Different urea solutions ranging from 1 mM to 100 mM
were used in order to test the proposed sensor by means
of the DPV technique. In Figure 4 the DPV for the phosphate buffer blank (a), a 100 mM urea solution (b),
a 1 mg/mL urease solution (c), and a 100 mM urea-urease
system (d) are presented. Before any voltage is applied to
the electrochemical cell, the biochemical reaction between the substrate (i.e. urea) and the enzyme was allowed to equilibrate for five minutes for the enzyme to
start degrading the urea, producing ammonia in order to
have a measurable current.
As can be observed, a different current-potential profile is obtained when comparing the urea-urease system
against the blanks. In the graph corresponding to the
urea-urease system (Fig. 4d), a distinguishable peak was
observed around 0.0 V vs. Ag/AgCl, which belongs to the
ammonia oxidation. For the urea and enzyme blanks, this
peak was more like a shoulder with negligible current.
Also, in these two blanks as in the urea-urease experiments, a broad peak was observed between 0.2 V and
0.7 V vs. Ag/AgCl, therefore it may be related to the
buffer, a common specie for all solutions. However, in the
buffer blank a strong peak was observed, suggesting that
the presences of other species are able to attenuate the
buffer signal. After testing the proposed device, two important features of the sensor were determined, sensitivity
and selectivity. First, the sensitivity indicates the minimum
measurable urea concentration and the signal variation
due to increasing urea concentration. To determine the
sensitivity of the sensor the construction of a calibration
curve was performed. The differential pulse voltammetry
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Fig. 4. Differential pulse voltammetry: (a) blank buffer, (b) 100 mM urea solution, (c) 1 mg/mL urease solution and (d) 100 mM
urea-urease system at pH 8.3. Pulse height of 50 mV, pulse duration of 50 ms, step height of 2 mV, and step duration of 400 ms.

(DPV) was used as a very sensitive method with sub-micromolar detection limit Thus, for such calibration curve
urea solutions ranging from 1 mM to 25 mM were analyzed in the bioprobe device. The results showed an increment in the anodic wave due to increasing concentration
of urea as can be observed in Figure 5a.
A linear dynamic range from 1 mM to 25 mM with a detection limit of 1.79 mM (S/N = 3) is obtained for urea detection with a slope of 0.343 mA cm2/mM and a correlation coefficient (R2) of 0.9980, see Figure 5b. The results
of the analytical determination of urea by this method
are sensitive enough to enable the construction of biosensors for clinical and analytical applications. In fact, the
sensitivity of this system is similar to other urea bioprobes
and biosensors reported in the literature [19–21]. Although more recent investigations have shown the enhanced urea determination to limits of detection of
10 mM and linear range of 20 mM due to the use of
hybrid materials containing nanofiber[22].
3.4 Selectivity Measurements (Interference)
As abovementioned, two important features for any
sensor are, sensitivity and selectivity. The sensitivity of the
proposed sensor was determined previously with the calibration curves. Now, in order to determine the selectivity
of the sensor, a compound similar in size and composition
to urea is measured. From the different nitrogenous
based compounds, creatinine was chosen to be studied as
interference for the urea sensor, due to its similar size
and structure to urea, but also for its presence in blood
(i.e. 50–130 mM) [23, 24]. Another important argument to
2106
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use creatinine as an interferent is that this compound is
found in concentrations that are ten times higher for patients with kidney problems [25].
Creatinine, as urea, is not an electroactive specie as
ammonia. Therefore when a solution of creatinine was
measured in the biosensor no significant current was obtained, as with blank urea. Then, when a mixture of creatinine and urease was measured in the sensor, no current
was obtained, meaning that the enzyme did not produce
any ammonia because its selectivity towards urea. Finally,
it was found that creatinine does not inhibit the enzymes
activity, since urease was able to degrade urea in the presence of creatinine, where a significant current was measured.

4 Conclusions
A bioelectrochemical device capable of measuring urea
at levels of clinical importance was developed. The biosensor developed is capable of measuring urea levels as
low as 1.79 mM which is in the normal range (i.e. 2.5–
7 mM) for a healthy individual. Moreover, the linear
range presented by this sensor enables measurements of
higher urea levels. Another analytical importance feature
of the present method is that the presence of other similar molecules does not show considerable effects on the
anodic peak current of ammonia. Therefore, the presented biosensor can be considered as a very sensitive and
reasonably selective approach for urea determination.
Further investigations will assess the selectivity of the
sensor in presence of complex matrixes such as blood.
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Fig. 6. Creatinine linear polarization: (a) 50 mM of creatinine,
10 mM of urea, and 0.5 mg/mL of urease in 100 mM PBS solution, (b) 50 mM of creatinine 100 mM PBS solution, (c) 50 mM
of creatinine and 0.5 mg/mL of urease in 100 mM PBS solution.
Scan rate of 5 mV/s.
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